Black Rock Inc. Inhibrx, Inc. Transaction History

Black Rock Inc.

$4.23 Trillion
Q1 2024

A detailed history of Black Rock Inc. transactions in Inhibrx, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 2,751,705 shares of INBX stock, worth $39 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,751,705

Previous 2,715,672 1.33%

Holding current value

$39 Million

Previous $103 Million 6.78%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$32.76 - $39.56 $1.18 Million - $1.43 Million	36,033 Added 1.33%	2,751,705 $96.2 Million
Q4 2023 Feb 13, 2024	BUY	$14.5 - $38.0 $2.55 Million - $6.68 Million	175,899 Added 6.93%	2,715,672 $103 Million
Q3 2023 Nov 13, 2023	SELL	$15.75 - $26.31 $107,572 - $179,697	-6,830 Reduced 0.27%	2,539,773 $46.6 Million
Q2 2023 Aug 11, 2023	BUY	$16.96 - $27.82 $3.62 Million - $5.94 Million	213,678 Added 9.16%	2,546,603 $66.1 Million
Q1 2023 May 12, 2023	SELL	$18.45 - $27.14 $1.54 Million - $2.26 Million	-83,263 Reduced 3.45%	2,332,925 $44 Million

Q4 2022 Feb 13, 2023	BUY	$20.18 - $33.33 $4.55 Million - $7.52 Million	225,670 Added 10.3%	2,416,188 $59.5 Million
Q3 2022 Nov 14, 2022	BUY	$11.58 - $24.73 $2.47 Million - $5.28 Million	213,407 Added 10.79%	2,190,518 $39.3 Million
Q2 2022 Aug 12, 2022	BUY	$8.52 - $25.26 $638,693 - $1.89 Million	74,964 Added 3.94%	1,977,111 $22.4 Million
Q1 2022 May 12, 2022	BUY	$19.89 - $43.18 $152,755 - $331,622	7,680 Added 0.41%	1,902,147 $42.4 Million
Q4 2021 Feb 10, 2022	BUY	$26.75 - $46.02 $6.2 Million - $10.7 Million	231,936 Added 13.95%	1,894,467 $82.7 Million
Q3 2021 Nov 09, 2021	BUY	$25.18 - $37.81 $4.16 Million - $6.25 Million	165,358 Added 11.04%	1,662,531 $55.4 Million
Q2 2021 Aug 11, 2021	BUY	$14.69 - $27.52 $22 Million - $41.2 Million	1,497,173 New	1,497,173 $41.2 Million

Others Institutions Holding INBX

# of Institutions

132

Shares Held

35.5M

Call Options Held

64.8K

Put Options Held

91.3K

View Full List

About Inhibrx, Inc.

Ticker INBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,057,700
Market Cap $553M
Description
Inhibrx, Inc., a clinical-stage biotechnology company, focuses on developing a pipeline of novel biologic therapeutic candidates. The company's therapeutic candidates include INBRX-109, a tetravalent agonist of death receptor 5, which is in Phase 2 clinical trials to treat cancers, such as chondrosarcoma, mesothelioma, and pancreatic adenocarcin...

More about INBX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account